FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely to new amino acid derivatives of 3,4-dimethoxyphenylethylamine 1-4 exhibiting anxiolytic activity and described by general formula (1-4). In the formula, R represents
NH represents (COOH)2 (1-4); Y = 1 (1, 2); Y = 3 (3); Y = 0 (4).
EFFECT: preparation of an anxiolytic compound.
2 cl, 6 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED 2-[2(3-OXOMORPHOLIN-4-YL)ETHYLTHIO]BENZIMIDAZOLES, WITH ANXIOLYTIC ACTIVITY | 2007 |
|
RU2373202C2 |
APPLICATION OF 1-HETARYL-2-NITRO-2-(3-PHENYL-1,2,4-OXADIAZOLE-5-YL)ETHANES AS PSYCHOTROPIC SUBSTANCES | 2009 |
|
RU2420521C1 |
AGENT SHOWING ANXIOLYTIC ACTION | 2011 |
|
RU2464990C1 |
1,4-BENZODIAZEPINE DERIVATIVES SHOWING SELECTIVE ANXIOLYTIC ACTIVITY | 1995 |
|
RU2133248C1 |
ANXIOLYTIC AND CEREBROPROTECTIVE AGENT REDUCING INCLINATION TO ALCOHOL | 2008 |
|
RU2393855C1 |
QUINAZOLINE DERIVATIVES, POSSESSING ANTIDEPRESSANT, ANXIOLYTIC AND NOOTROPIC ACTIVITY | 2012 |
|
RU2507199C1 |
METHOD FOR CORRECTION OF SECONDARY IMMUNODEFICIENCY IN CALVES | 2012 |
|
RU2525426C2 |
2-SUBSTITUTED 5-(HETERO)ALKYL-6-HYDROXYPYRIMIDINE-4(1H)-ONES WITH ANXIOLYTIC ACTIVITY | 2021 |
|
RU2793570C1 |
METHOD OF PREVENTING COMPLICATIONS IN HYSTEROMYOMA IN CASE OF HYSTERECTOMY | 2007 |
|
RU2354361C1 |
SUBSTANCE ENHANCING RESISTANCE OF CARDIAC MUSCLE AGAINST ISCHEMIA | 2005 |
|
RU2292886C1 |
Authors
Dates
2010-09-10—Published
2008-06-16—Filed